Search filters

List of works by Jeremie H Estepp

A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy.

scientific article published on 14 September 2017

Complexities of genetic diagnosis illustrated by an atypical case of congenital hypoplastic anemia

scientific article published on 17 December 2018

Development of the InCharge Health Mobile App to Improve Adherence to Hydroxyurea in Patients With Sickle Cell Disease: User-Centered Design Approach

scientific article published on 08 May 2020

Hydroxycarbamide in children with sickle cell anaemia after first-dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure.

scientific article published on 8 September 2017

Hydroxyurea prevents onset and progression of albuminuria in children with sickle cell anemia

scientific article published on 29 November 2018

Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia

scientific article published on 17 August 2014

MAGiC: VOC remains but kids with SCA appear.

scientific article published in October 2015

Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.

scientific article published on 22 June 2016

Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia

scientific article published on 22 July 2015

Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children

scientific article published on 06 February 2013

Safe Use of Low-Molecular-weight Heparin in Pediatric Acute Lymphoblastic Leukemia and Lymphoma Around Lumbar Punctures

scientific article published on 4 October 2017

Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood

scientific article published on 24 May 2018

The clinical severity of hemoglobin S/Black ((A) γδβ)(0) -thalassemia

scientific article published on 28 April 2017

The impact of quality and duration of enoxaparin therapy on recurrent venous thrombosis in children

scientific article

Voxelotor (GBT440), a first-in-class hemoglobin oxygen-affinity modulator, has promising and reassuring preclinical and clinical data

scientific article published on 20 January 2018

Paulina is supported by:

About Paulina

Help